FDA has approved Genentech’s CD20-targeting antibody obinutuzumab (Gazyva) for the treatment of adult patients with lupus nephritis who are receiving standard therapy. https://t.co/0eGwGnSDYf https://t.co/wnQDVnTEjb
Links:
FDA Approves Third-Ever Drug for Lupus Nephritis
https://buff.ly/gmn2vup
Oct-25-2025
